SCHEMBL31387327

SCHEMBL31387327

Nc1nnc(N2CCC(=C(F)F)CC2)[nH]1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5174107 0.75 CYP1A2 (0.37) —
SCHEMBL31387185 0.68 GAA (0.56) —
SCHEMBL11200914 0.63 PARP1 (0.36) —
SCHEMBL31554233 0.61 — —
SCHEMBL24816957 0.60 GRIN2D (0.55) —
SCHEMBL11205135 0.59 HTR1A (0.55) —
SCHEMBL24816960 0.59 ADRA2C (0.54) —
SCHEMBL24815805 0.58 KMT2A (0.41) —
SCHEMBL14589051 0.57 SETD7 (0.45) —
SCHEMBL24817000 0.57 ALDH1A1 (0.39) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024255765-A1 NOVEL COMPOUNDS, COMPOSITIONS COMPRISING THE SAME AND USES THEREOF NUPHASE THERAPEUTICS (HANGZHOU) LIMITED., CO. (CN) 2024-12-19 — — WO disclosed
Send feedback